US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atea Pharmaceuticals, Inc.

2.87

+0.02000.70%

Volume:580.39K

Turnover:1.64M

Market Cap:245.46M

PE:-1.44

High:2.88

Open:2.88

Low:2.78

Close:2.85

Loading ...

Overview Company News Filings

Radoff Bradley Louis Reports 3.3% Stake in Atea Pharmaceuticals as of Feb 27 - SEC Filing

THOMSON REUTERS

Radoff Bradley Louis - Intend to Nominate a Competing Slate of Candidates for Election to Atea Pharmaceuticals' Board at Upcoming Annual Meeting

THOMSON REUTERS

Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 6, 2025

Atea Pharmaceuticals Inc expected to post a loss of 37 cents a share - Earnings Preview

Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors

THOMSON REUTERS

Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors

Atea Pharmaceuticals to Highlight 2025 Strategic Priorities at the 43Rd Annual J.p. Morgan Healthcare Conference

THOMSON REUTERS

Atea Pharmaceuticals Inc: Cash Runway Anticipated Into 2028

THOMSON REUTERS

Atea Pharmaceuticals Inc - Reports Cash Balance of $454.7 Million at Dec 31, 2024

THOMSON REUTERS

Atea Pharmaceuticals to Highlight 2025 Strategic Priorities at the 43rd Annual J.P. Morgan Healthcare Conference

BRIEF-Bradley L. Radoff And Michael Torok Calls For Atea Pharmaceuticals To Appoint New, Lead Independent Director To Oversee Strategic Review Process

Bradley L. Radoff and Michael Torok: Collectively Own About 3% of Outstanding Shares of Atea Pharmaceuticals

THOMSON REUTERS

Bradley L. Radoff and Michael Torok: Calls for Atea Pharmaceuticals to Appoint New, Lead Independent Director to Oversee Strategic Review Process

THOMSON REUTERS

Atea Pharmaceuticals retains financial advisor to explore partnerships

Atea Pharmaceuticals Retains Financial Advisor to Explore Strategic Partnerships

THOMSON REUTERS

Atea Pharmaceuticals Retains Financial Advisor to Explore Strategic Partnerships

After Failed COVID-19 Drug Trial, Atea Pharmaceuticals Touts Encouraging Data From Mid-Stage Hepatitis C Study

BUZZ-Atea Pharma rises as combo drug meets main goal in mid-stage study

Atea Pharmaceuticals announces results from Phase 2 regimen of bemnifosbuvir

Atea Pharmaceuticals Inc: Global Phase 3 Program Initiation Expected Early in 2025

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/AVIR/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVIR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVIR\",,,,,undefined,":{"symbol":"AVIR","market":"US","secType":"STK","nameCN":"Atea Pharmaceuticals, Inc.","latestPrice":2.87,"timestamp":1745524800000,"preClose":2.85,"halted":0,"volume":580389,"delay":0,"floatShares":66356403,"shares":85525179,"eps":-1.998285,"marketStatus":"Pre-Mkt","change":0.02,"latestTime":"04-25 06:03:36 EDT","open":2.88,"high":2.88,"low":2.78,"amount":1640510.218289,"amplitude":0.035088,"askPrice":3.27,"askSize":100,"bidPrice":2.7,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-1.998285,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745587800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1604030400000,"exchange":"NASDAQ","adjPreClose":2.87,"postHourTrading":{"tag":"盘后","latestPrice":2.87,"preClose":2.87,"latestTime":"16:05 EDT","volume":7957,"amount":22836.59,"timestamp":1745525109816},"volumeRatio":0.8628826177379628,"impliedVol":1.6809,"impliedVolPercentile":0.6667},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVIR\",,,,,undefined,":{"symbol":"AVIR","floatShares":66356403,"roa":"-15.60%","roe":"-33.88%","lyrEps":-1.998285,"volumeRatio":0.8628826177379628,"shares":85525179,"dividePrice":0,"high":2.88,"amplitude":0.035088,"preClose":2.85,"low":2.78,"week52Low":2.6,"pbRate":"0.56","psRate":"1.28","week52High":4.145,"institutionHeld":0.4276,"latestPrice":2.87,"committee":0.666667,"eps":-1.998285,"divideRate":0,"volume":580389,"delay":0,"ttmEps":-1.998285,"open":2.88,"prevYearClose":3.35,"prevWeekClose":2.97,"prevMonthClose":2.99,"prevQuarterClose":2.99,"fiveDayClose":3,"twentyDayClose":3.18,"sixtyDayClose":3.1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVIR\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516672232","title":"Radoff Bradley Louis Reports 3.3% Stake in Atea Pharmaceuticals as of Feb 27 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2516672232","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516672232?lang=en_us&edition=fundamental","pubTime":"2025-03-04 22:41","pubTimestamp":1741099303,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PN0NI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2516672219","title":"Radoff Bradley Louis - Intend to Nominate a Competing Slate of Candidates for Election to Atea Pharmaceuticals' Board at Upcoming Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2516672219","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516672219?lang=en_us&edition=fundamental","pubTime":"2025-03-04 22:41","pubTimestamp":1741099303,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PN0NI:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2514806551","title":"Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 6, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2514806551","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514806551?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:00","pubTimestamp":1740657600,"startTime":"0","endTime":"0","summary":"BOSTON, Feb.  27, 2025  (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3033676/0/en/Atea-Pharmaceuticals-to-Host-Fourth-Quarter-and-Full-Year-2024-Financial-Results-Conference-Call-on-March-6-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4181","BK4218","HST","AVIR","BK4585"],"gpt_icon":0},{"id":"2514570496","title":"Atea Pharmaceuticals Inc  expected to post a loss of 37 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2514570496","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514570496?lang=en_us&edition=fundamental","pubTime":"2025-02-25 06:19","pubTimestamp":1740435546,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals Inc  expected to post a loss of37cents a share - Earnings Preview Atea Pharmaceuticals Inc AVIR.OQ AVIR.O is expected to show no change in quarterly revenue when it reports  resul","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL5N3PF2I8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR"],"gpt_icon":0},{"id":"2513408447","title":"Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2513408447","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513408447?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nTUA1LMSRV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AVIR","LQDA"],"gpt_icon":0},{"id":"2513406257","title":"Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2513406257","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513406257?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398400,"startTime":"0","endTime":"0","summary":"BOSTON, Feb. 24, 2025  -- Atea Pharmaceuticals, Inc.  , a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.Mr. Kirsch is currently a Senior Advisor with Alvarez & Marsal's Life Sciences Industry Group, and over the course of his 30-year career has held numerous roles in mergers and acquisitions and equity capital markets at global investment banks. Over that time, he executed a wide range of strategic advisory assignments for clients in the healthcare and life sciences industries as well as numerous public and private financings.Atea is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/atea-pharmaceuticals-appoints-arthur-kirsch-120000516.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LQDA","AVIR"],"gpt_icon":0},{"id":"2503967308","title":"Atea Pharmaceuticals to Highlight 2025 Strategic Priorities at the 43Rd Annual J.p. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2503967308","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503967308?lang=en_us&edition=fundamental","pubTime":"2025-01-13 20:00","pubTimestamp":1736769601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nTUABD9369:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2503446308","title":"Atea Pharmaceuticals Inc: Cash Runway Anticipated Into 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2503446308","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503446308?lang=en_us&edition=fundamental","pubTime":"2025-01-13 20:00","pubTimestamp":1736769601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nTUABD9369:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2503084283","title":"Atea Pharmaceuticals Inc - Reports Cash Balance of $454.7 Million at Dec 31, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2503084283","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503084283?lang=en_us&edition=fundamental","pubTime":"2025-01-13 20:00","pubTimestamp":1736769601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nTUABD9369:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2503303946","title":"Atea Pharmaceuticals to Highlight 2025 Strategic Priorities at the 43rd Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2503303946","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503303946?lang=en_us&edition=fundamental","pubTime":"2025-01-13 20:00","pubTimestamp":1736769600,"startTime":"0","endTime":"0","summary":"Global Phase 3 HCV Program Expected to Initiate in 1Q 2025 Potential Best-in-Class Profile of Bemnifosbuvir + Ruzasvir Regimen Supports Opportunity to Disrupt and Expand Global HCV Market of Approxima","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/13/3008323/0/en/Atea-Pharmaceuticals-to-Highlight-2025-Strategic-Priorities-at-the-43rd-Annual-J-P-Morgan-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU0106261372.USD","BK4127","LU1989772840.SGD","AVIR","LU1732800096.USD","LU1720051017.SGD","LU2089284900.SGD","LU0158827948.USD","LU1363072403.SGD","BK4007","LU2347655156.SGD","LU0314104364.USD","LU2357305700.SGD","BK4504","LU2271345857.HKD","LU2111349929.HKD","HCSG","BK4218","BK4581","LU0006306889.USD","BK4588","LU2023251221.USD","LU2028103732.USD","SOF","LU0971096721.USD","LU0795875169.SGD","BK4137","BK4516","BK4585","LU1074936037.SGD","LU0225283273.USD","LU1162221912.USD","LU0795875086.SGD","LU0098860793.USD","PK","LU0158827781.USD","LU0267386448.USD","BK4181","IE00BZ1G4Q59.USD","LU0320765646.SGD","IE00BKVL7J92.USD","LU2089283258.USD","LU0106831901.USD","LU1989772923.USD","LU0912757837.SGD","LU1732799900.SGD","LU1668664300.SGD","LU1548497426.USD","LU1720051108.HKD"],"gpt_icon":0},{"id":"2492816848","title":"BRIEF-Bradley L. Radoff And Michael Torok Calls For Atea Pharmaceuticals To Appoint New, Lead Independent Director To Oversee Strategic Review Process","url":"https://stock-news.laohu8.com/highlight/detail?id=2492816848","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492816848?lang=en_us&edition=fundamental","pubTime":"2024-12-19 06:32","pubTimestamp":1734561120,"startTime":"0","endTime":"0","summary":"Dec 18 (Reuters) -    * BRADLEY L. RADOFF AND MICHAEL TOROK: CALLS FOR ATEA PHARMACEUTICALS TO APPOINT NEW, LEAD INDEPENDENT DIRECTOR TO OVERSEE STRATEGIC REVIEW PROCESS   * BRADLEY L. RADOFF AND MICH","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2492689051","title":"Bradley L. Radoff and Michael Torok: Collectively Own About 3% of Outstanding Shares of Atea Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2492689051","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492689051?lang=en_us&edition=fundamental","pubTime":"2024-12-19 06:28","pubTimestamp":1734560886,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nFWN3NJ0TL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2492168988","title":"Bradley L. Radoff and Michael Torok: Calls for Atea Pharmaceuticals to Appoint New, Lead Independent Director to Oversee Strategic Review Process","url":"https://stock-news.laohu8.com/highlight/detail?id=2492168988","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492168988?lang=en_us&edition=fundamental","pubTime":"2024-12-19 06:28","pubTimestamp":1734560886,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nFWN3NJ0TL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2491166385","title":"Atea Pharmaceuticals retains financial advisor to explore partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=2491166385","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491166385?lang=en_us&edition=fundamental","pubTime":"2024-12-16 18:10","pubTimestamp":1734343809,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals (AVIR) announced that it has engaged Evercore to identify potential opportunities to enhance shareholder value, including the ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atea-pharmaceuticals-retains-financial-advisor-to-explore-partnerships?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atea-pharmaceuticals-retains-financial-advisor-to-explore-partnerships?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2491686166","title":"Atea Pharmaceuticals Retains Financial Advisor to Explore Strategic Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=2491686166","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491686166?lang=en_us&edition=fundamental","pubTime":"2024-12-16 18:00","pubTimestamp":1734343206,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nFWN3NF02E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2491668194","title":"Atea Pharmaceuticals Retains Financial Advisor to Explore Strategic Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=2491668194","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491668194?lang=en_us&edition=fundamental","pubTime":"2024-12-16 18:00","pubTimestamp":1734343200,"startTime":"0","endTime":"0","summary":"BOSTON, Dec.  16, 2024  (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral ant","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/16/2997278/0/en/Atea-Pharmaceuticals-Retains-Financial-Advisor-to-Explore-Strategic-Partnerships.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR"],"gpt_icon":0},{"id":"2489296144","title":"After Failed COVID-19 Drug Trial, Atea Pharmaceuticals Touts Encouraging Data From Mid-Stage Hepatitis C Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2489296144","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489296144?lang=en_us&edition=fundamental","pubTime":"2024-12-05 04:14","pubTimestamp":1733343258,"startTime":"0","endTime":"0","summary":"On Wednesday, Atea Pharmaceuticals, Inc.  released Phase 2 study data from the regimen of bemnifosbuvir and ruzasvir for the hepatitis C virus infection that causes liver swelling andcan lead to serious liver damage.The study met its primary endpoints of safety and sustained virologic response at 12 weeks post-treatment .Primary endpoint results demonstrated a 98%  SVR12 rate in the per-protocol treatment adherent patient population after eight weeks of treatment with a regimen of bemnifosbuvir and ruzasvir.Also Read: Atea Pharmaceuticals’ COVID-19 Treatment Flunks In Late-Stage Study, Blames’ Constantly Evolving’ Virus. The efficacy evaluable patient population, which included 17% treatment non-adherent patients, achieved a 95%  SVR12 rate demonstrating the potency and forgiveness of the regimen.In June, Atea Pharmaceuticals shared new data from the lead-in cohort  of its ongoing Phase 2 combination study of bemnifosbuvir and ruzasvir forhepatitis C virus.The regimen was generally saf","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/FMsScQo8bQujiB2D8yd.rA--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/aea084d777829ea6e71337923d1865b0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/FMsScQo8bQujiB2D8yd.rA--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/aea084d777829ea6e71337923d1865b0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/failed-covid-19-drug-trial-201418711.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BNTX","AVIR","SSI","BK4007"],"gpt_icon":0},{"id":"2488019334","title":"BUZZ-Atea Pharma rises as combo drug meets main goal in mid-stage study","url":"https://stock-news.laohu8.com/highlight/detail?id=2488019334","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488019334?lang=en_us&edition=fundamental","pubTime":"2024-12-04 21:03","pubTimestamp":1733317437,"startTime":"0","endTime":"0","summary":"BUZZ-Atea Pharma rises as combo drug meets main goal in mid-stage study** Shares of drug developer Atea Pharmaceuticals AVIR.O rise 6.9% to $3.72 premarket ** Co says its drug combination met the main goal for treating Hepatitis C Virus  in a mid-stage study** The combination of bemnifosbuvir and ruzasvir showed 98% success rate in eliminating HCV, co says** Bemnifosbuvir and ruzasvir are both oral antiviral medications to treat HCV ** HCV is a leading cause of chronic liver diseases and liver transplants, affecting around 50 mln people worldwide** As of last close, stock had risen 14.1% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nL3N3N50TN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2488676751","title":"Atea Pharmaceuticals announces results from Phase 2 regimen of bemnifosbuvir","url":"https://stock-news.laohu8.com/highlight/detail?id=2488676751","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488676751?lang=en_us&edition=fundamental","pubTime":"2024-12-04 20:06","pubTimestamp":1733314011,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals (AVIR) announced that the Company’s Phase 2 study of the regimen of bemnifosbuvir, a nucleotide analog polymerase inhibitor, a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atea-pharmaceuticals-announces-results-from-phase-2-regimen-of-bemnifosbuvir?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atea-pharmaceuticals-announces-results-from-phase-2-regimen-of-bemnifosbuvir?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2488519551","title":"Atea Pharmaceuticals Inc: Global Phase 3 Program Initiation Expected Early in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2488519551","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488519551?lang=en_us&edition=fundamental","pubTime":"2024-12-04 20:00","pubTimestamp":1733313602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nTUABWTBX9:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVIR","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":78,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVIR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-06","symbol":"AVIR","fiscalQuarterEnding":"2024/12","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":-0.4},{"market":"US","date":"2024-11-07","symbol":"AVIR","fiscalQuarterEnding":"2024/09","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.37},{"market":"US","date":"2024-08-07","symbol":"AVIR","fiscalQuarterEnding":"2024/06","expectedEps":-0.77,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-0.48},{"market":"US","date":"2024-05-14","symbol":"AVIR","fiscalQuarterEnding":"2024/03","expectedEps":-0.61,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":-0.75},{"market":"US","date":"2024-02-28","symbol":"AVIR","fiscalQuarterEnding":"2023/12","expectedEps":-0.44,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709096400000,"reportTimeType":"post","actualEps":-0.47}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVIR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVIR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0,"hold":0.3333,"sell":0.3333,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.3333,"analysts":3,"updateTime":1723521600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AVIR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AVIR","date":"2025-04-23","current":-1.457715,"percent":0.558659,"low":-466.703742,"twenty":-2.632085,"median":-1.599931,"eighty":27.04857,"high":114.976269,"avg":-9.819679,"sd":77.753398,"marketCap":245457263},"quantilePoints":[{"date":"2020-10-30","current":-171.312553,"twenty":-156.993218,"median":-135.514215,"eighty":-135.514215,"marketCap":2404200368},{"date":"2020-11-06","current":-192.938363,"twenty":-185.270517,"median":-169.618626,"eighty":-144.887281,"marketCap":2707696987},{"date":"2020-11-13","current":-182.492476,"twenty":-179.57892,"median":-166.738948,"eighty":-150.14975,"marketCap":2561099403},{"date":"2020-11-20","current":-187.291937,"twenty":-185.891624,"median":-173.26057,"eighty":-154.847576,"marketCap":2628455050},{"date":"2020-11-27","current":-194.462898,"twenty":-190.555572,"median":-181.814905,"eighty":-159.059809,"marketCap":2729092310},{"date":"2020-12-04","current":-165.157949,"twenty":-189.166551,"median":-180.855012,"eighty":-159.059809,"marketCap":2317826657},{"date":"2020-12-11","current":-67.833477,"twenty":-188.274415,"median":-172.131284,"eighty":-157.207782,"marketCap":2459506214},{"date":"2020-12-18","current":-77.722536,"twenty":-187.969508,"median":-166.738948,"eighty":-135.514215,"marketCap":2818063721},{"date":"2020-12-24","current":-78.565613,"twenty":-187.291937,"median":-160.979594,"eighty":-78.793471,"marketCap":2848631987},{"date":"2020-12-31","current":-95.199284,"twenty":-184.491311,"median":-158.946881,"eighty":-79.413246,"marketCap":3451735627},{"date":"2021-01-08","current":-109.508798,"twenty":-183.384611,"median":-157.817596,"eighty":-81.91969,"marketCap":3970569992},{"date":"2021-01-15","current":-121.767585,"twenty":-182.650576,"median":-148.839779,"eighty":-87.757425,"marketCap":4415049113},{"date":"2021-01-22","current":-123.658811,"twenty":-181.67939,"median":-135.514215,"eighty":-89.411678,"marketCap":4483621170},{"date":"2021-01-29","current":-166.336709,"twenty":-180.96794,"median":-133.570656,"eighty":-92.48321,"marketCap":6031036401},{"date":"2021-02-05","current":-196.09503,"twenty":-183.486247,"median":-135.514215,"eighty":-94.775467,"marketCap":7110013598},{"date":"2021-02-12","current":-186.912332,"twenty":-187.630723,"median":-154.457973,"eighty":-95.135484,"marketCap":6777067342},{"date":"2021-02-19","current":-190.558068,"twenty":-189.772842,"median":-158.862185,"eighty":-95.217512,"marketCap":6909254441},{"date":"2021-02-26","current":-171.71417,"twenty":-189.772842,"median":-159.511523,"eighty":-96.684921,"marketCap":6226012372},{"date":"2021-03-05","current":-136.669532,"twenty":-188.951987,"median":-160.201207,"eighty":-99.647082,"marketCap":4955363881},{"date":"2021-03-12","current":-154.624782,"twenty":-188.240537,"median":-158.890417,"eighty":-101.734266,"marketCap":5606385344},{"date":"2021-03-19","current":-177.934707,"twenty":-187.800115,"median":-159.27838,"eighty":-104.710098,"marketCap":6451556610},{"date":"2021-03-26","current":-137.079677,"twenty":-187.140095,"median":-158.946881,"eighty":-108.114304,"marketCap":4970234929},{"date":"2021-04-01","current":-436.925398,"twenty":-188.274415,"median":-159.045237,"eighty":-110.534161,"marketCap":4783022327},{"date":"2021-04-09","current":-427.100056,"twenty":-190.548954,"median":-160.935243,"eighty":-115.451347,"marketCap":4675464309},{"date":"2021-04-16","current":-339.654512,"twenty":-191.931363,"median":-165.157949,"eighty":-119.324942,"marketCap":3718197948},{"date":"2021-04-23","current":-275.185154,"twenty":-195.768604,"median":-167.331823,"eighty":-122.091144,"marketCap":3012451876},{"date":"2021-04-30","current":-186.757076,"twenty":-199.196041,"median":-171.312553,"eighty":-123.440067,"marketCap":2044429713},{"date":"2021-05-07","current":-161.135608,"twenty":-197.99537,"median":-168.007959,"eighty":-124.055285,"marketCap":1763951496},{"date":"2021-05-14","current":79.797223,"twenty":-196.113259,"median":-166.426176,"eighty":-123.440067,"marketCap":1895503226},{"date":"2021-05-21","current":78.125347,"twenty":-195.768604,"median":-164.402964,"eighty":-110.534161,"marketCap":1855789496},{"date":"2021-05-28","current":71.124369,"twenty":-194.157991,"median":-160.979594,"eighty":-99.246051,"marketCap":1689488253},{"date":"2021-06-04","current":74.990581,"twenty":-192.938363,"median":-159.511523,"eighty":-95.039783,"marketCap":1781326253},{"date":"2021-06-11","current":82.757835,"twenty":-192.37372,"median":-159.183468,"eighty":-82.507565,"marketCap":1965829623},{"date":"2021-06-18","current":81.469098,"twenty":-191.978471,"median":-158.890417,"eighty":-77.722536,"marketCap":1935216956},{"date":"2021-06-25","current":82.931989,"twenty":-191.742933,"median":-157.410556,"eighty":-69.975347,"marketCap":1969966469},{"date":"2021-07-02","current":81.08596,"twenty":-190.990999,"median":-154.624782,"eighty":67.989602,"marketCap":1926115893},{"date":"2021-07-09","current":80.075869,"twenty":-190.877549,"median":-153.804491,"eighty":71.451777,"marketCap":1902122181},{"date":"2021-07-16","current":79.762392,"twenty":-190.616292,"median":-149.016908,"eighty":72.482768,"marketCap":1894675857},{"date":"2021-07-23","current":87.459985,"twenty":-190.521611,"median":-146.01173,"eighty":76.523133,"marketCap":2077524488},{"date":"2021-07-30","current":87.21617,"twenty":-190.129695,"median":-138.834187,"eighty":78.278602,"marketCap":2071732902},{"date":"2021-08-06","current":108.532582,"twenty":-189.511691,"median":-136.601174,"eighty":79.811155,"marketCap":2578082956},{"date":"2021-08-13","current":64.910668,"twenty":-188.522858,"median":-135.134867,"eighty":80.20126,"marketCap":2290437846},{"date":"2021-08-20","current":69.578982,"twenty":-188.17278,"median":-133.639014,"eighty":79.908681,"marketCap":2455163951},{"date":"2021-08-27","current":73.543529,"twenty":-187.46133,"median":-129.708455,"eighty":79.811155,"marketCap":2595056974},{"date":"2021-09-03","current":67.819567,"twenty":-186.988253,"median":-125.64118,"eighty":79.769358,"marketCap":2393081248},{"date":"2021-09-10","current":67.092343,"twenty":-186.819178,"median":-123.385381,"eighty":79.6579,"marketCap":2367420398},{"date":"2021-09-17","current":61.532592,"twenty":-186.754529,"median":-116.674948,"eighty":79.170269,"marketCap":2171239057},{"date":"2021-09-24","current":75.396779,"twenty":-185.83684,"median":-107.184641,"eighty":78.431857,"marketCap":2660450755},{"date":"2021-10-01","current":98.550675,"twenty":-184.365164,"median":-99.847598,"eighty":79.353564,"marketCap":3477459123},{"date":"2021-10-08","current":93.976197,"twenty":-183.486247,"median":-95.199284,"eighty":79.950478,"marketCap":3316044096},{"date":"2021-10-15","current":92.146406,"twenty":-182.808676,"median":-92.009265,"eighty":81.232249,"marketCap":3251478085},{"date":"2021-10-22","current":29.86313,"twenty":-182.369073,"median":-82.507565,"eighty":81.232249,"marketCap":1053750408},{"date":"2021-10-29","current":27.306114,"twenty":-181.597122,"median":-78.679542,"eighty":81.099892,"marketCap":963523546},{"date":"2021-11-05","current":25.359029,"twenty":-180.96794,"median":-70.955139,"eighty":80.856077,"marketCap":894818688},{"date":"2021-11-12","current":38.198876,"twenty":-179.102829,"median":-70.055098,"eighty":80.32665,"marketCap":944047012},{"date":"2021-11-19","current":27.2705,"twenty":-177.005044,"median":-64.575101,"eighty":79.950478,"marketCap":673963140},{"date":"2021-11-26","current":27.371377,"twenty":-176.330583,"median":25.218276,"eighty":79.83902,"marketCap":676456222},{"date":"2021-12-03","current":27.102371,"twenty":-176.111839,"median":25.704021,"eighty":79.783291,"marketCap":669808003},{"date":"2021-12-10","current":26.799739,"twenty":-175.627494,"median":26.093598,"eighty":79.69273,"marketCap":662328758},{"date":"2021-12-17","current":28.750034,"twenty":-174.603768,"median":26.564359,"eighty":79.431789,"marketCap":710528341},{"date":"2021-12-23","current":30.633077,"twenty":-173.693594,"median":26.850178,"eighty":79.136017,"marketCap":757065870},{"date":"2021-12-31","current":30.061439,"twenty":-173.535454,"median":27.03512,"eighty":78.738368,"marketCap":742938406},{"date":"2022-01-07","current":25.690089,"twenty":-172.807662,"median":27.068745,"eighty":77.999956,"marketCap":634904857},{"date":"2022-01-14","current":24.546813,"twenty":-172.137986,"median":26.900617,"eighty":77.393902,"marketCap":606649929},{"date":"2022-01-21","current":21.654996,"twenty":-171.736956,"median":26.766114,"eighty":76.975933,"marketCap":535181581},{"date":"2022-01-28","current":22.865524,"twenty":-171.71417,"median":26.328978,"eighty":76.662456,"marketCap":565098564},{"date":"2022-02-04","current":23.000027,"twenty":-171.312553,"median":26.093598,"eighty":76.488302,"marketCap":568422673},{"date":"2022-02-11","current":22.66377,"twenty":-168.09122,"median":25.807779,"eighty":75.396779,"marketCap":560112400},{"date":"2022-02-18","current":19.906456,"twenty":-167.924698,"median":25.690089,"eighty":75.396779,"marketCap":491968161},{"date":"2022-02-25","current":21.419616,"twenty":-166.976098,"median":25.359029,"eighty":75.378012,"marketCap":529364390},{"date":"2022-03-04","current":3.948735,"twenty":-166.48873,"median":24.788709,"eighty":75.073047,"marketCap":478547148},{"date":"2022-03-11","current":3.976204,"twenty":-166.354602,"median":24.479561,"eighty":74.992061,"marketCap":481876171},{"date":"2022-03-18","current":4.862094,"twenty":-165.393701,"median":23.807046,"eighty":74.851258,"marketCap":589237184},{"date":"2022-03-25","current":4.745349,"twenty":-163.949973,"median":23.269033,"eighty":74.398458,"marketCap":575088833},{"date":"2022-04-01","current":4.875829,"twenty":-161.638082,"median":23.117718,"eighty":74.106492,"marketCap":590901696},{"date":"2022-04-08","current":4.573665,"twenty":-161.010797,"median":23.000027,"eighty":73.646748,"marketCap":554282436},{"date":"2022-04-14","current":4.525593,"twenty":-160.926372,"median":22.865524,"eighty":73.205722,"marketCap":548456644},{"date":"2022-04-22","current":4.044878,"twenty":-160.06327,"median":22.058506,"eighty":72.410188,"marketCap":490198730},{"date":"2022-04-29","current":4.032693,"twenty":-159.488323,"median":21.654996,"eighty":71.812079,"marketCap":488722059},{"date":"2022-05-06","current":3.792243,"twenty":-159.382162,"median":21.503681,"eighty":71.654826,"marketCap":459581902},{"date":"2022-05-13","current":12.540245,"twenty":-159.155821,"median":20.915229,"eighty":71.605033,"marketCap":606947838},{"date":"2022-05-20","current":12.884284,"twenty":-158.986223,"median":20.141837,"eighty":71.560583,"marketCap":623599356},{"date":"2022-05-27","current":14.071221,"twenty":-158.913003,"median":19.502947,"eighty":71.524315,"marketCap":681047094},{"date":"2022-06-03","current":13.417546,"twenty":-158.867831,"median":13.555162,"eighty":71.479642,"marketCap":649409209},{"date":"2022-06-10","current":13.27993,"twenty":-158.508321,"median":13.709979,"eighty":71.312455,"marketCap":642748602},{"date":"2022-06-17","current":11.181288,"twenty":-157.53242,"median":13.53796,"eighty":70.650671,"marketCap":541174341},{"date":"2022-06-24","current":12.265013,"twenty":-156.71581,"median":13.27993,"eighty":69.928889,"marketCap":593626623},{"date":"2022-07-01","current":12.557447,"twenty":-156.024233,"median":12.93589,"eighty":69.874563,"marketCap":607780414},{"date":"2022-07-08","current":13.606767,"twenty":-154.624782,"median":12.93589,"eighty":69.837029,"marketCap":658567544},{"date":"2022-07-15","current":13.933605,"twenty":-154.533639,"median":13.27993,"eighty":69.719735,"marketCap":674386487},{"date":"2022-07-22","current":13.761585,"twenty":-153.804491,"median":13.443349,"eighty":69.602441,"marketCap":666060728},{"date":"2022-07-29","current":14.105625,"twenty":-152.114706,"median":13.555162,"eighty":69.578982,"marketCap":682712246},{"date":"2022-08-05","current":15.120542,"twenty":-149.194038,"median":13.675575,"eighty":69.156722,"marketCap":731834224},{"date":"2022-08-12","current":45.098857,"twenty":-148.839779,"median":13.813191,"eighty":68.570251,"marketCap":700204851},{"date":"2022-08-19","current":44.187227,"twenty":-148.362663,"median":13.881999,"eighty":68.523333,"marketCap":686050888},{"date":"2022-08-26","current":41.988591,"twenty":-146.01173,"median":13.933605,"eighty":68.030697,"marketCap":651914861},{"date":"2022-09-02","current":39.95083,"twenty":-143.642002,"median":14.019615,"eighty":67.989602,"marketCap":620276592},{"date":"2022-09-09","current":42.256717,"twenty":-141.199359,"median":14.06262,"eighty":67.909876,"marketCap":656077791},{"date":"2022-09-16","current":35.98256,"twenty":-137.781481,"median":14.088423,"eighty":67.833642,"marketCap":558665226},{"date":"2022-09-23","current":31.10266,"twenty":-136.751561,"median":14.217438,"eighty":67.500527,"marketCap":482899897},{"date":"2022-09-30","current":30.512782,"twenty":-136.614846,"median":14.535674,"eighty":67.27063,"marketCap":473741451},{"date":"2022-10-07","current":28.957649,"twenty":-135.731607,"median":14.862512,"eighty":67.176794,"marketCap":449596456},{"date":"2022-10-14","current":28.15327,"twenty":-135.514215,"median":19.872831,"eighty":67.106418,"marketCap":437107665},{"date":"2022-10-21","current":28.528647,"twenty":-134.907259,"median":20.562159,"eighty":66.974213,"marketCap":442935767},{"date":"2022-10-28","current":31.638913,"twenty":-134.153974,"median":21.38599,"eighty":66.781304,"marketCap":491225757},{"date":"2022-11-04","current":32.389666,"twenty":-133.711929,"median":21.604558,"eighty":65.670736,"marketCap":502881962},{"date":"2022-11-11","current":12.077105,"twenty":-132.636436,"median":21.38599,"eighty":65.403305,"marketCap":430597093},{"date":"2022-11-18","current":10.909106,"twenty":-131.930075,"median":20.562159,"eighty":65.103031,"marketCap":388953274},{"date":"2022-11-25","current":10.955826,"twenty":-129.286916,"median":19.889643,"eighty":64.999812,"marketCap":390619026},{"date":"2022-12-02","current":11.212786,"twenty":-126.766801,"median":15.120542,"eighty":64.938819,"marketCap":399780667},{"date":"2022-12-09","current":10.255027,"twenty":-125.869038,"median":14.552876,"eighty":64.150601,"marketCap":365632735},{"date":"2022-12-16","current":10.768946,"twenty":-124.451759,"median":14.260443,"eighty":62.377111,"marketCap":383956015},{"date":"2022-12-23","current":10.722226,"twenty":-123.494753,"median":14.097024,"eighty":61.180709,"marketCap":382290263},{"date":"2022-12-30","current":11.236146,"twenty":-122.738263,"median":14.071221,"eighty":55.100568,"marketCap":400613543},{"date":"2023-01-06","current":10.979186,"twenty":-121.156924,"median":14.045418,"eighty":46.278613,"marketCap":391451903},{"date":"2023-01-13","current":11.516465,"twenty":-117.898548,"median":13.950807,"eighty":46.053387,"marketCap":410608060},{"date":"2023-01-20","current":11.446386,"twenty":-114.635614,"median":13.899201,"eighty":46.010486,"marketCap":408109431},{"date":"2023-01-27","current":10.745586,"twenty":-109.508798,"median":13.856196,"eighty":45.903236,"marketCap":383123139},{"date":"2023-02-03","current":10.535347,"twenty":-107.184641,"median":13.761585,"eighty":45.474234,"marketCap":375627251},{"date":"2023-02-10","current":9.834548,"twenty":-103.060402,"median":13.659535,"eighty":45.098857,"marketCap":350640960},{"date":"2023-02-17","current":9.927987,"twenty":-100.850175,"median":13.555162,"eighty":44.937981,"marketCap":353972465},{"date":"2023-02-24","current":8.573109,"twenty":-99.246051,"median":13.469152,"eighty":44.466079,"marketCap":305665635},{"date":"2023-03-03","current":-2.538161,"twenty":-95.964888,"median":13.331536,"eighty":44.219402,"marketCap":294195756},{"date":"2023-03-10","current":-2.401547,"twenty":-95.208398,"median":12.953092,"eighty":44.144327,"marketCap":278360857},{"date":"2023-03-17","current":-2.710728,"twenty":-95.071683,"median":12.884284,"eighty":43.9191,"marketCap":314197733},{"date":"2023-03-24","current":-2.157078,"twenty":-94.511151,"median":12.695062,"eighty":43.736775,"marketCap":250024722},{"date":"2023-03-31","current":-2.408737,"twenty":-90.587427,"median":12.600452,"eighty":43.532999,"marketCap":279194272},{"date":"2023-04-05","current":-2.415927,"twenty":-89.411678,"median":12.557447,"eighty":43.425749,"marketCap":280027688},{"date":"2023-04-14","current":-2.423117,"twenty":-86.44496,"median":12.505841,"eighty":43.221972,"marketCap":280861104},{"date":"2023-04-21","current":-2.344024,"twenty":-81.331815,"median":12.282215,"eighty":42.953846,"marketCap":271693531},{"date":"2023-04-28","current":-2.379976,"twenty":-79.258302,"median":12.230609,"eighty":42.578469,"marketCap":275860609},{"date":"2023-05-05","current":-2.396017,"twenty":-78.702328,"median":12.100465,"eighty":42.149467,"marketCap":277719925},{"date":"2023-05-12","current":-2.525658,"twenty":-78.228382,"median":11.92588,"eighty":41.83844,"marketCap":276051937},{"date":"2023-05-19","current":-2.739309,"twenty":-75.015577,"median":11.731751,"eighty":41.570314,"marketCap":299403763},{"date":"2023-05-26","current":-3.53287,"twenty":-70.863995,"median":11.512296,"eighty":41.205661,"marketCap":386139115},{"date":"2023-06-02","current":-3.113198,"twenty":-70.608794,"median":11.483414,"eighty":40.647959,"marketCap":340269458},{"date":"2023-06-09","current":-3.258176,"twenty":-70.102948,"median":11.446386,"eighty":40.186782,"marketCap":356115339},{"date":"2023-06-16","current":-3.166611,"twenty":-69.546973,"median":11.318087,"eighty":40.036631,"marketCap":346107414},{"date":"2023-06-23","current":-2.983482,"twenty":-67.833477,"median":11.259506,"eighty":39.95083,"marketCap":326091564},{"date":"2023-06-30","current":-2.861395,"twenty":-65.226776,"median":11.224466,"eighty":39.95083,"marketCap":312747663},{"date":"2023-07-07","current":-2.75457,"twenty":-28.146626,"median":11.197037,"eighty":39.182114,"marketCap":301071750},{"date":"2023-07-14","current":-2.861395,"twenty":-3.801459,"median":11.166066,"eighty":38.537448,"marketCap":312747663},{"date":"2023-07-21","current":-2.807983,"twenty":-3.706843,"median":11.072626,"eighty":38.299055,"marketCap":306909707},{"date":"2023-07-28","current":-2.540919,"twenty":-3.6107,"median":11.002546,"eighty":38.198876,"marketCap":277719925},{"date":"2023-08-04","current":-2.640114,"twenty":-3.548131,"median":10.967506,"eighty":37.383889,"marketCap":288561844},{"date":"2023-08-11","current":-2.663513,"twenty":-3.496244,"median":10.955826,"eighty":36.776214,"marketCap":282723888},{"date":"2023-08-18","current":-2.67137,"twenty":-3.448936,"median":10.920786,"eighty":36.282862,"marketCap":283557881},{"date":"2023-08-25","current":-2.639942,"twenty":-3.383314,"median":10.909106,"eighty":35.775559,"marketCap":280221906},{"date":"2023-09-01","current":-2.639942,"twenty":-3.29938,"median":10.885746,"eighty":34.557553,"marketCap":280221906},{"date":"2023-09-08","current":-2.577086,"twenty":-3.262754,"median":10.803986,"eighty":33.730299,"marketCap":273549956},{"date":"2023-09-15","current":-2.577086,"twenty":-3.258176,"median":10.768946,"eighty":33.569423,"marketCap":273549956},{"date":"2023-09-21","current":-2.498516,"twenty":-3.22155,"median":10.768946,"eighty":33.151146,"marketCap":265210018},{"date":"2023-10-06","current":-2.364948,"twenty":-3.197133,"median":10.768946,"eighty":32.872294,"marketCap":251032124},{"date":"2023-10-09","current":-2.33352,"twenty":-3.191029,"median":10.768946,"eighty":32.797219,"marketCap":247696149},{"date":"2023-10-17","current":-2.357091,"twenty":-3.184924,"median":10.757266,"eighty":32.722143,"marketCap":250198131},{"date":"2023-11-01","current":-2.553515,"twenty":-3.172715,"median":10.733906,"eighty":32.571992,"marketCap":271047975},{"date":"2023-11-10","current":-1.900308,"twenty":-3.162033,"median":10.710546,"eighty":32.464742,"marketCap":249364137},{"date":"2023-11-17","current":-1.850265,"twenty":-3.149824,"median":10.675507,"eighty":32.429404,"marketCap":242797342},{"date":"2023-11-24","current":-1.812115,"twenty":-3.14372,"median":10.628787,"eighty":32.407954,"marketCap":237791212},{"date":"2023-12-01","current":-1.901132,"twenty":-3.140668,"median":10.582067,"eighty":32.303866,"marketCap":249472183},{"date":"2023-12-08","current":-1.86934,"twenty":-3.129985,"median":10.535347,"eighty":32.153715,"marketCap":245300408},{"date":"2023-12-15","current":-1.894773,"twenty":-3.117777,"median":10.42211,"eighty":31.956565,"marketCap":248637828},{"date":"2023-12-22","current":-1.996506,"twenty":-3.10099,"median":10.266707,"eighty":31.681026,"marketCap":261987510},{"date":"2023-12-29","current":-1.971073,"twenty":-3.082677,"median":10.255027,"eighty":31.638913,"marketCap":258650090},{"date":"2024-01-05","current":-1.971073,"twenty":-3.064364,"median":10.231667,"eighty":31.638913,"marketCap":258650090},{"date":"2024-01-12","current":-2.276271,"twenty":-3.047577,"median":10.184947,"eighty":31.478037,"marketCap":298699136},{"date":"2024-01-19","current":-2.269913,"twenty":-3.035369,"median":10.004174,"eighty":31.263536,"marketCap":297864781},{"date":"2024-01-26","current":-2.397079,"twenty":-3.006373,"median":9.834548,"eighty":31.085409,"marketCap":314551884},{"date":"2024-02-02","current":-2.683202,"twenty":-2.946856,"median":9.577588,"eighty":31.055333,"marketCap":352097864},{"date":"2024-02-09","current":-2.708636,"twenty":-2.891917,"median":9.390708,"eighty":30.990254,"marketCap":355435285},{"date":"2024-02-16","current":-2.676844,"twenty":-2.888865,"median":8.806709,"eighty":30.896513,"marketCap":351263509},{"date":"2024-02-23","current":-2.562395,"twenty":-2.882761,"median":6.674963,"eighty":30.855984,"marketCap":336245117},{"date":"2024-03-01","current":-2.668137,"twenty":-2.882761,"median":4.999441,"eighty":30.721892,"marketCap":362749188},{"date":"2024-03-08","current":-2.525754,"twenty":-2.873604,"median":4.937635,"eighty":30.686879,"marketCap":343391343},{"date":"2024-03-15","current":-2.38337,"twenty":-2.861395,"median":4.862094,"eighty":30.626352,"marketCap":324033498},{"date":"2024-03-22","current":-2.538135,"twenty":-2.859869,"median":4.779686,"eighty":30.582117,"marketCap":345074634},{"date":"2024-03-28","current":-2.476229,"twenty":-2.853765,"median":4.714446,"eighty":30.512782,"marketCap":336658180},{"date":"2024-04-05","current":-2.38337,"twenty":-2.838504,"median":4.601134,"eighty":30.431323,"marketCap":324033498},{"date":"2024-04-12","current":-2.38337,"twenty":-2.823244,"median":4.553063,"eighty":30.405531,"marketCap":324033498},{"date":"2024-04-19","current":-2.290512,"twenty":-2.823244,"median":4.525593,"eighty":30.351906,"marketCap":311408816},{"date":"2024-04-26","current":-2.284321,"twenty":-2.815613,"median":4.46722,"eighty":30.08378,"marketCap":310567171},{"date":"2024-05-03","current":-2.372639,"twenty":-2.815613,"median":4.353909,"eighty":30.061439,"marketCap":322574473},{"date":"2024-05-10","current":-2.434588,"twenty":-2.807983,"median":4.312705,"eighty":30.030154,"marketCap":330996783},{"date":"2024-05-17","current":-1.904126,"twenty":-2.800352,"median":4.257766,"eighty":29.976529,"marketCap":311625470},{"date":"2024-05-24","current":-1.89898,"twenty":-2.792722,"median":4.22424,"eighty":29.910048,"marketCap":310783239},{"date":"2024-05-31","current":-1.85781,"twenty":-2.783638,"median":4.207069,"eighty":29.872514,"marketCap":304045391},{"date":"2024-06-07","current":-1.955589,"twenty":-2.778242,"median":4.154756,"eighty":29.844363,"marketCap":320047780},{"date":"2024-06-14","current":-1.904126,"twenty":-2.777461,"median":4.051745,"eighty":29.76091,"marketCap":311625470},{"date":"2024-06-21","current":-1.76003,"twenty":-2.777461,"median":4.044878,"eighty":29.688214,"marketCap":288043002},{"date":"2024-06-28","current":-1.739445,"twenty":-2.777461,"median":4.032693,"eighty":29.668025,"marketCap":284674078},{"date":"2024-07-05","current":-1.687982,"twenty":-2.777461,"median":3.976204,"eighty":29.559513,"marketCap":276251768},{"date":"2024-07-12","current":-1.734299,"twenty":-2.763867,"median":3.884237,"eighty":29.461726,"marketCap":283831847},{"date":"2024-07-15","current":-1.765176,"twenty":-2.759336,"median":3.860943,"eighty":29.451001,"marketCap":288885233},{"date":"2024-08-02","current":-1.868102,"twenty":-2.754805,"median":3.826593,"eighty":29.440276,"marketCap":305729853},{"date":"2024-08-09","current":-1.678875,"twenty":-2.75457,"median":3.661713,"eighty":29.440276,"marketCap":295477000},{"date":"2024-08-16","current":-1.793998,"twenty":-2.753144,"median":-1.61172,"eighty":29.220795,"marketCap":315738280},{"date":"2024-08-23","current":-1.813185,"twenty":-2.746785,"median":-1.641665,"eighty":29.220795,"marketCap":319115160},{"date":"2024-08-30","current":-1.813185,"twenty":-2.742082,"median":-1.683428,"eighty":29.17215,"marketCap":319115160},{"date":"2024-09-06","current":-1.736437,"twenty":-2.739864,"median":-1.687982,"eighty":29.086853,"marketCap":305607640},{"date":"2024-09-13","current":-1.760421,"twenty":-2.724943,"median":-1.693128,"eighty":29.001437,"marketCap":309828740},{"date":"2024-09-20","current":-1.832372,"twenty":-2.712853,"median":-1.726843,"eighty":28.985414,"marketCap":322492040},{"date":"2024-09-27","current":-1.650094,"twenty":-2.709176,"median":-1.703421,"eighty":28.963202,"marketCap":290411680},{"date":"2024-10-04","current":-1.59733,"twenty":-2.708666,"median":-1.687982,"eighty":28.871848,"marketCap":281125260},{"date":"2024-10-11","current":-1.602127,"twenty":-2.708636,"median":-1.687982,"eighty":28.797008,"marketCap":281969480},{"date":"2024-10-18","current":-1.789201,"twenty":-2.688289,"median":-1.687982,"eighty":28.756759,"marketCap":314894060},{"date":"2024-10-25","current":-1.621314,"twenty":-2.682118,"median":-1.687982,"eighty":28.750034,"marketCap":285346360},{"date":"2024-10-31","current":-1.573346,"twenty":-2.680275,"median":-1.687982,"eighty":28.629674,"marketCap":276904160},{"date":"2024-11-08","current":-1.668975,"twenty":-2.679227,"median":-1.678875,"eighty":28.536962,"marketCap":290411680},{"date":"2024-11-15","current":-1.606684,"twenty":-2.677797,"median":-1.672543,"eighty":28.464296,"marketCap":279572725},{"date":"2024-11-22","current":-1.57756,"twenty":-2.676844,"median":-1.669129,"eighty":28.421396,"marketCap":274504941},{"date":"2024-11-29","current":-1.660079,"twenty":-2.674654,"median":-1.659884,"eighty":28.357046,"marketCap":288863661},{"date":"2024-12-06","current":-1.422231,"twenty":-2.671016,"median":-1.660079,"eighty":28.23907,"marketCap":247476762},{"date":"2024-12-13","current":-1.431939,"twenty":-2.669546,"median":-1.652631,"eighty":28.185445,"marketCap":249166024},{"date":"2024-12-20","current":-1.519312,"twenty":-2.666287,"median":-1.650094,"eighty":28.152215,"marketCap":264369374},{"date":"2024-12-27","current":-1.596976,"twenty":-2.661942,"median":-1.641665,"eighty":28.145941,"marketCap":277883464},{"date":"2025-01-03","current":-1.660079,"twenty":-2.655656,"median":-1.640501,"eighty":28.127174,"marketCap":288863661},{"date":"2025-01-10","current":-1.621246,"twenty":-2.655656,"median":-1.640501,"eighty":28.070873,"marketCap":282106617},{"date":"2025-01-17","current":-1.616392,"twenty":-2.649327,"median":-1.635704,"eighty":27.992672,"marketCap":281261986},{"date":"2025-01-24","current":-1.50475,"twenty":-2.646707,"median":-1.633539,"eighty":27.93629,"marketCap":261835482},{"date":"2025-01-31","current":-1.451355,"twenty":-2.645438,"median":-1.630955,"eighty":27.830492,"marketCap":252544546},{"date":"2025-02-07","current":-1.50475,"twenty":-2.64209,"median":-1.626106,"eighty":27.755914,"marketCap":261835482},{"date":"2025-02-14","current":-1.509604,"twenty":-2.640114,"median":-1.621314,"eighty":27.677227,"marketCap":262680113},{"date":"2025-02-21","current":-1.524166,"twenty":-2.640045,"median":-1.616517,"eighty":27.578237,"marketCap":265214005},{"date":"2025-02-28","current":-1.485334,"twenty":-2.639942,"median":-1.616392,"eighty":27.458272,"marketCap":258456960},{"date":"2025-03-07","current":-1.523743,"twenty":-2.639942,"median":-1.616392,"eighty":27.391553,"marketCap":256575537},{"date":"2025-03-14","current":-1.554218,"twenty":-2.639942,"median":-1.609231,"eighty":27.345272,"marketCap":261707047},{"date":"2025-03-21","current":-1.599931,"twenty":-2.639443,"median":-1.606923,"eighty":27.291868,"marketCap":269404313},{"date":"2025-03-28","current":-1.533902,"twenty":-2.63621,"median":-1.610089,"eighty":27.2705,"marketCap":258286040},{"date":"2025-04-04","current":-1.472952,"twenty":-2.632425,"median":-1.606923,"eighty":27.2436,"marketCap":248023019},{"date":"2025-04-11","current":-1.36629,"twenty":-2.632236,"median":-1.606804,"eighty":27.162898,"marketCap":230062731},{"date":"2025-04-17","current":-1.523743,"twenty":-2.632085,"median":-1.601978,"eighty":27.088921,"marketCap":256575537},{"date":"2025-04-23","current":-1.457715,"twenty":-2.632085,"median":-1.599931,"eighty":27.04857,"marketCap":245457263}],"updateTime":1745556815795}}}